| Year |
Citation |
Score |
| 2011 |
Sozio SM, Coresh J, Jaar BG, Fink NE, Plantinga LC, Armstrong PA, Longenecker JC, Sharrett AR, Powe NR, Parekh RS. Inflammatory markers and risk of cerebrovascular events in patients initiating dialysis. Clinical Journal of the American Society of Nephrology : Cjasn. 6: 1292-300. PMID 21551022 DOI: 10.2215/Cjn.08350910 |
0.473 |
|
| 2008 |
Longenecker JC, Coresh J, Klag MJ, Powe NR, Fink NE, Marcovina SM. Lipoprotein(a) level as a predictor of cardiovascular disease and small apoliprotein(a) isoforms in dialysis patients: assay-related differences are important. Clinica Chimica Acta; International Journal of Clinical Chemistry. 397: 36-41. PMID 18692032 DOI: 10.1016/J.Cca.2008.07.012 |
0.482 |
|
| 2005 |
Longenecker JC, Klag MJ, Marcovina SM, Liu YM, Jaar BG, Powe NR, Fink NE, Levey AS, Coresh J. High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis patients. Journal of the American Society of Nephrology : Jasn. 16: 1794-802. PMID 15800123 DOI: 10.1681/Asn.2004110922 |
0.594 |
|
| 2004 |
Fox CS, Longenecker JC, Powe NR, Klag MJ, Fink NE, Parekh R, Coresh J. Undertreatment of hyperlipidemia in a cohort of United States kidney dialysis patients. Clinical Nephrology. 61: 299-307. PMID 15182124 DOI: 10.5414/Cnp61299 |
0.466 |
|
| 2004 |
Liu Y, Coresh J, Eustace JA, Longenecker JC, Jaar B, Fink NE, Tracy RP, Powe NR, Klag MJ. Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition. Jama. 291: 451-9. PMID 14747502 DOI: 10.1001/Jama.291.4.451 |
0.58 |
|
| 2003 |
Longenecker JC, Coresh J, Marcovina SM, Powe NR, Levey AS, Giaculli F, Fink NE, Klag MJ. Lipoprotein(a) and prevalent cardiovascular disease in a dialysis population: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) study. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 42: 108-16. PMID 12830462 DOI: 10.1016/S0272-6386(03)00413-X |
0.567 |
|
| 2002 |
Longenecker JC, Klag MJ, Marcovina SM, Powe NR, Fink NE, Giaculli F, Coresh J. Small apolipoprotein(a) size predicts mortality in end-stage renal disease: The CHOICE study. Circulation. 106: 2812-8. PMID 12451008 DOI: 10.1161/01.Cir.0000038946.91899.Bb |
0.598 |
|
| 2002 |
Kovesdy CP, Astor BC, Longenecker JC, Coresh J. Association of kidney function with serum lipoprotein(a) level: the third National Health and Nutrition Examination Survey (1991-1994). American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 40: 899-908. PMID 12407633 DOI: 10.1053/Ajkd.2002.36319 |
0.511 |
|
| 2002 |
Longenecker JC, Coresh J, Powe NR, Levey AS, Fink NE, Martin A, Klag MJ. Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study. Journal of the American Society of Nephrology : Jasn. 13: 1918-27. PMID 12089389 DOI: 10.1097/01.Asn.0000019641.41496.1E |
0.485 |
|
| 2002 |
Astor BC, Eustace JA, Klag MJ, Powe NR, Longenecker JC, Fink NE, Marcovina SM, Coresh J. Race-specific association of lipoprotein(a) with vascular access interventions in hemodialysis patients: the CHOICE Study. Kidney International. 61: 1115-23. PMID 11849466 DOI: 10.1046/J.1523-1755.2002.00194.X |
0.558 |
|
| 2000 |
Longenecker JC, Coresh J, Klag MJ, Levey AS, Martin AA, Fink NE, Powe NR. Validation of comorbid conditions on the end-stage renal disease medical evidence report: the CHOICE study. Choices for Healthy Outcomes in Caring for ESRD. Journal of the American Society of Nephrology : Jasn. 11: 520-9. PMID 10703676 |
0.408 |
|
| 1998 |
Coresh J, Longenecker JC, Miller ER, Young HJ, Klag MJ. Epidemiology of cardiovascular risk factors in chronic renal disease. Journal of the American Society of Nephrology : Jasn. 9: S24-30. PMID 11443765 |
0.492 |
|
| Show low-probability matches. |